These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21896007)

  • 1. The emerging role of HLA-C in HIV-1 infection.
    Kulpa DA; Collins KL
    Immunology; 2011 Oct; 134(2):116-22. PubMed ID: 21896007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA-C and HIV-1: friends or foes?
    Zipeto D; Beretta A
    Retrovirology; 2012 May; 9():39. PubMed ID: 22571741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA Class I Downregulation by HIV-1 Variants from Subtype C Transmission Pairs.
    Ende Z; Deymier MJ; Claiborne DT; Prince JL; Mónaco DC; Kilembe W; Allen SA; Hunter E
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29321314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Counteraction of HLA-C-mediated immune control of HIV-1 by Nef.
    Specht A; Telenti A; Martinez R; Fellay J; Bailes E; Evans DT; Carrington M; Hahn BH; Goldstein DB; Kirchhoff F
    J Virol; 2010 Jul; 84(14):7300-11. PubMed ID: 20463068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
    Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
    J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presence of HLA-C-restricted cytotoxic T-lymphocyte responses in long-term nonprogressors infected with human immunodeficiency virus.
    Nehete PN; Lewis DE; Tang DN; Pollack MS; Sastry KJ
    Viral Immunol; 1998; 11(3):119-29. PubMed ID: 9918403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability and Expression Levels of HLA-C on the Cell Membrane Modulate HIV-1 Infectivity.
    Parolini F; Biswas P; Serena M; Sironi F; Muraro V; Guizzardi E; Cazzoletti L; Scupoli MT; Gibellini D; Ugolotti E; Biassoni R; Beretta A; Malnati M; Romanelli MG; Zipeto D
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29070683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of HIV-1 by an HLA-B*52:01-C*12:02 Protective Haplotype.
    Chikata T; Murakoshi H; Koyanagi M; Honda K; Gatanaga H; Oka S; Takiguchi M
    J Infect Dis; 2017 Dec; 216(11):1415-1424. PubMed ID: 28968792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1: a molecular toolkit for analysis of major histocompatibility complex class I expression.
    Howcroft TK
    Eur J Clin Invest; 2000 Aug; 30(8):657-9. PubMed ID: 10964156
    [No Abstract]   [Full Text] [Related]  

  • 10. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.
    ; Pereyra F; Jia X; McLaren PJ; Telenti A; de Bakker PI; Walker BD; Ripke S; Brumme CJ; Pulit SL; Carrington M; Kadie CM; Carlson JM; Heckerman D; Graham RR; Plenge RM; Deeks SG; Gianniny L; Crawford G; Sullivan J; Gonzalez E; Davies L; Camargo A; Moore JM; Beattie N; Gupta S; Crenshaw A; Burtt NP; Guiducci C; Gupta N; Gao X; Qi Y; Yuki Y; Piechocka-Trocha A; Cutrell E; Rosenberg R; Moss KL; Lemay P; O'Leary J; Schaefer T; Verma P; Toth I; Block B; Baker B; Rothchild A; Lian J; Proudfoot J; Alvino DM; Vine S; Addo MM; Allen TM; Altfeld M; Henn MR; Le Gall S; Streeck H; Haas DW; Kuritzkes DR; Robbins GK; Shafer RW; Gulick RM; Shikuma CM; Haubrich R; Riddler S; Sax PE; Daar ES; Ribaudo HJ; Agan B; Agarwal S; Ahern RL; Allen BL; Altidor S; Altschuler EL; Ambardar S; Anastos K; Anderson B; Anderson V; Andrady U; Antoniskis D; Bangsberg D; Barbaro D; Barrie W; Bartczak J; Barton S; Basden P; Basgoz N; Bazner S; Bellos NC; Benson AM; Berger J; Bernard NF; Bernard AM; Birch C; Bodner SJ; Bolan RK; Boudreaux ET; Bradley M; Braun JF; Brndjar JE; Brown SJ; Brown K; Brown ST; Burack J; Bush LM; Cafaro V; Campbell O; Campbell J; Carlson RH; Carmichael JK; Casey KK; Cavacuiti C; Celestin G; Chambers ST; Chez N; Chirch LM; Cimoch PJ; Cohen D; Cohn LE; Conway B; Cooper DA; Cornelson B; Cox DT; Cristofano MV; Cuchural G; Czartoski JL; Dahman JM; Daly JS; Davis BT; Davis K; Davod SM; DeJesus E; Dietz CA; Dunham E; Dunn ME; Ellerin TB; Eron JJ; Fangman JJ; Farel CE; Ferlazzo H; Fidler S; Fleenor-Ford A; Frankel R; Freedberg KA; French NK; Fuchs JD; Fuller JD; Gaberman J; Gallant JE; Gandhi RT; Garcia E; Garmon D; Gathe JC; Gaultier CR; Gebre W; Gilman FD; Gilson I; Goepfert PA; Gottlieb MS; Goulston C; Groger RK; Gurley TD; Haber S; Hardwicke R; Hardy WD; Harrigan PR; Hawkins TN; Heath S; Hecht FM; Henry WK; Hladek M; Hoffman RP; Horton JM; Hsu RK; Huhn GD; Hunt P; Hupert MJ; Illeman ML; Jaeger H; Jellinger RM; John M; Johnson JA; Johnson KL; Johnson H; Johnson K; Joly J; Jordan WC; Kauffman CA; Khanlou H; Killian RK; Kim AY; Kim DD; Kinder CA; Kirchner JT; Kogelman L; Kojic EM; Korthuis PT; Kurisu W; Kwon DS; LaMar M; Lampiris H; Lanzafame M; Lederman MM; Lee DM; Lee JM; Lee MJ; Lee ET; Lemoine J; Levy JA; Llibre JM; Liguori MA; Little SJ; Liu AY; Lopez AJ; Loutfy MR; Loy D; Mohammed DY; Man A; Mansour MK; Marconi VC; Markowitz M; Marques R; Martin JN; Martin HL; Mayer KH; McElrath MJ; McGhee TA; McGovern BH; McGowan K; McIntyre D; Mcleod GX; Menezes P; Mesa G; Metroka CE; Meyer-Olson D; Miller AO; Montgomery K; Mounzer KC; Nagami EH; Nagin I; Nahass RG; Nelson MO; Nielsen C; Norene DL; O'Connor DH; Ojikutu BO; Okulicz J; Oladehin OO; Oldfield EC; Olender SA; Ostrowski M; Owen WF; Pae E; Parsonnet J; Pavlatos AM; Perlmutter AM; Pierce MN; Pincus JM; Pisani L; Price LJ; Proia L; Prokesch RC; Pujet HC; Ramgopal M; Rathod A; Rausch M; Ravishankar J; Rhame FS; Richards CS; Richman DD; Rodes B; Rodriguez M; Rose RC; Rosenberg ES; Rosenthal D; Ross PE; Rubin DS; Rumbaugh E; Saenz L; Salvaggio MR; Sanchez WC; Sanjana VM; Santiago S; Schmidt W; Schuitemaker H; Sestak PM; Shalit P; Shay W; Shirvani VN; Silebi VI; Sizemore JM; Skolnik PR; Sokol-Anderson M; Sosman JM; Stabile P; Stapleton JT; Starrett S; Stein F; Stellbrink HJ; Sterman FL; Stone VE; Stone DR; Tambussi G; Taplitz RA; Tedaldi EM; Telenti A; Theisen W; Torres R; Tosiello L; Tremblay C; Tribble MA; Trinh PD; Tsao A; Ueda P; Vaccaro A; Valadas E; Vanig TJ; Vecino I; Vega VM; Veikley W; Wade BH; Walworth C; Wanidworanun C; Ward DJ; Warner DA; Weber RD; Webster D; Weis S; Wheeler DA; White DJ; Wilkins E; Winston A; Wlodaver CG; van't Wout A; Wright DP; Yang OO; Yurdin DL; Zabukovic BW; Zachary KC; Zeeman B; Zhao M
    Science; 2010 Dec; 330(6010):1551-7. PubMed ID: 21051598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary HIV-1 Strains Use Nef To Downmodulate HLA-E Surface Expression.
    van Stigt Thans T; Akko JI; Niehrs A; Garcia-Beltran WF; Richert L; Stürzel CM; Ford CT; Li H; Ochsenbauer C; Kappes JC; Hahn BH; Kirchhoff F; Martrus G; Sauter D; Altfeld M; Hölzemer A
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31375574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of HLA-C expression level on HIV control.
    Apps R; Qi Y; Carlson JM; Chen H; Gao X; Thomas R; Yuki Y; Del Prete GQ; Goulder P; Brumme ZL; Brumme CJ; John M; Mallal S; Nelson G; Bosch R; Heckerman D; Stein JL; Soderberg KA; Moody MA; Denny TN; Zeng X; Fang J; Moffett A; Lifson JD; Goedert JJ; Buchbinder S; Kirk GD; Fellay J; McLaren P; Deeks SG; Pereyra F; Walker B; Michael NL; Weintrob A; Wolinsky S; Liao W; Carrington M
    Science; 2013 Apr; 340(6128):87-91. PubMed ID: 23559252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential microRNA regulation of HLA-C expression and its association with HIV control.
    Kulkarni S; Savan R; Qi Y; Gao X; Yuki Y; Bass SE; Martin MP; Hunt P; Deeks SG; Telenti A; Pereyra F; Goldstein D; Wolinsky S; Walker B; Young HA; Carrington M
    Nature; 2011 Apr; 472(7344):495-8. PubMed ID: 21499264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of human leukocyte antigen E and G in HIV infection.
    Tripathi P; Agrawal S
    AIDS; 2007 Jul; 21(11):1395-404. PubMed ID: 17589185
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunological control of chronic HIV-1 infection: HLA-mediated immune function and viral evolution in adolescents.
    Bansal A; Yue L; Conway J; Yusim K; Tang J; Kappes J; Kaslow RA; Wilson CM; Goepfert PA
    AIDS; 2007 Nov; 21(18):2387-97. PubMed ID: 18025875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional advantage of educated KIR2DL1(+) natural killer cells for anti-HIV-1 antibody-dependent activation.
    Gooneratne SL; Center RJ; Kent SJ; Parsons MS
    Clin Exp Immunol; 2016 Apr; 184(1):101-9. PubMed ID: 26647083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLA supertypes contribute in HIV type 1 cytotoxic T lymphocyte epitope clustering in Nef and Gag proteins.
    Chakraborty S; Rahman T; Chakravorty R; Kuchta A; Rabby A; Sahiuzzaman M
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):270-8. PubMed ID: 23061377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance of Major Histocompatibility Complex Class B (MHC-B) to Nef-Mediated Downregulation Relative to that of MHC-A Is Conserved among Primate Lentiviruses and Influences Antiviral T Cell Responses in HIV-1-Infected Individuals.
    Mwimanzi F; Toyoda M; Mahiti M; Mann JK; Martin JN; Bangsberg D; Brockman MA; Goulder P; Kirchhoff F; Brumme ZL; Ndung'u T; Ueno T
    J Virol; 2018 Jan; 92(1):. PubMed ID: 29046444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies and lentiviruses that specifically recognize a T cell epitope derived from HIV-1 Nef protein and presented by HLA-C.
    Herschhorn A; Marasco WA; Hizi A
    J Immunol; 2010 Dec; 185(12):7623-32. PubMed ID: 21076072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host determinants of HIV-1 control in African Americans.
    Pelak K; Goldstein DB; Walley NM; Fellay J; Ge D; Shianna KV; Gumbs C; Gao X; Maia JM; Cronin KD; Hussain SK; Carrington M; Michael NL; Weintrob AC; ;
    J Infect Dis; 2010 Apr; 201(8):1141-9. PubMed ID: 20205591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.